Clinical Trial Update: Study of Oral PG-116800 Following a Heart Attack [Phase 2]

View source ↗

Summary

Phase 2 trial of oral PG-116800 in patients after a heart attack has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomegaly
• Heart Failure
• Myocardial Infarction

Drugs mentioned

• PG-116800

Snippet

Sponsor: Procter and Gamble | Conditions: Myocardial Infarction, Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2011-11-04